Use of prostanoid ep4 receptor antagonists for the treatment of headache and assays for such antagonists

Details for Australian Patent Application No. 2000234451 (hide)

Owner Pharmagene Laboratories Ltd.

Inventors Coleman, Robert Alexander; Tilford, Nicholas; Baxter, Gordon Smith

Agent Blake Dawson Waldron

Pub. Number AU-B-2000234451

PCT Pub. Number WO01/72302

Filing date 24 March 2000

Wipo publication date 8 October 2001

Acceptance publication date 29 September 2005

International Classifications

A61K 031/421 - 1,3-Oxazoles, e.g. pemoline, trimethadione

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

A61P 025/06 Drugs for disorders of the nervous system

A61K 031/42 - Oxazoles

A61K 031/5375 - 1,4-Oxazines, e.g. morpholine

Event Publications

29 September 2005 Application Accepted

  Published as AU-B-2000234451

2 February 2006 Standard Patent Sealed

7 December 2006 Assignment Registered

  Pharmagene Laboratories Ltd The patent has been assigned to Asterand UK Limited

25 October 2012 Assignment Registered

  Asterand UK Limited The patent has been assigned to Asterand UK Acquisition Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2000234490

2000234356